Australia Health News API

{
    "totalArticles": 199850,
    "articles": [
        {
            "id": "cdb74e8b49e727cc7396f259ecf10d77",
            "title": "Chloe Houghton: Mum diagnosed with terminal lung cancer after being assured lump was harmless",
            "description": "The 32-year-old mother of two has been told that she has stage four cancer.",
            "content": "A young British mother who was told a growing lump on her chest was a harmless cyst has been diagnosed with terminal lung cancer.\nChloe Houghton, 32, received the heart-breaking diagnosis after months of seeking help for a lump, a few millilitres in ... [3488 chars]",
            "url": "https://thenightly.com.au/world/chloe-houghton-mum-diagnosed-with-terminal-lung-cancer-after-being-assured-lump-was-harmless-c-22470008",
            "image": "https://images.thenightly.com.au/publication/C-22470008/d73c27f74b4a47660b2b9ed78a19e3b03a0a608f-16x9-x0y35w557h313.webp?imwidth=1200",
            "publishedAt": "2026-06-23T01:53:40Z",
            "lang": "en",
            "source": {
                "id": "20bb5956d6815cfa1e442a067839d5a2",
                "name": "The Nightly",
                "url": "https://thenightly.com.au"
            }
        },
        {
            "id": "08b0b997681f3371fccb6ebae812ebf4",
            "title": "UN chief warns AIDS progress at risk from funding cuts",
            "description": "The progress made in dramatically reducing the number of AIDS deaths is under threat because of severe funding...",
            "content": "The UN General Assembly is holding a two-day meeting on HIV/AIDS. Photo: EPA PHOTO\nUN Secretary General António Guterres has warned that decades of progress in the fight against HIV/AIDS could be reversed by sharp cuts in international funding.\nSubsc... [3315 chars]",
            "url": "https://www.canberratimes.com.au/story/9297439/un-chief-warns-aids-progress-at-risk-from-funding-cuts/",
            "image": "https://www.canberratimes.com.au/images/transform/v1/crop/frm/silverstone-feed-data/bd00c56a-fb67-4984-ba99-0e98909ef1e1.jpg/r0_90_800_510_w1200_h630_fmax.jpg",
            "publishedAt": "2026-06-23T01:51:17Z",
            "lang": "en",
            "source": {
                "id": "a6f65972b4a593b55dffbc2b25866ab5",
                "name": "The Canberra Times",
                "url": "https://www.canberratimes.com.au"
            }
        },
        {
            "id": "960833f5b2c1e2d7abce536ee7384bf6",
            "title": "UQ drug QED-203 moves toward first in human trials with Ellison Medical Institute backing",
            "description": "UniQuest and the Ellison Medical Institute have signed an exclusive licence that could push a promising University of Queensland treatment for advanced prostate cancer into first-in-human trials as early as 2027.",
            "content": "UniQuest and the Ellison Medical Institute have signed an exclusive licence that could push a promising University of Queensland treatment for advanced prostate cancer into first-in-human trials as early as 2027.\nThe small molecule therapeutic, QED-2... [1885 chars]",
            "url": "https://biotechdispatch.com.au/news/uq-drug-qed-203-moves-toward-first-in-human-trials-with-ellison-medical-institute-backing",
            "image": "https://pharmadispatch.s3.us-west-or.io.cloud.ovh.us/889bf2aaa36369cc379fea52d6b17d3f.jpg",
            "publishedAt": "2026-06-23T01:39:13Z",
            "lang": "en",
            "source": {
                "id": "104a5dae25d39499f9898e1270e497fd",
                "name": "Biotech Dispatch",
                "url": "https://biotechdispatch.com.au"
            }
        }
    ]
}